Skye Bioscience (SKYE)
Developing an investigational peripheral cannabinoid-receptor antibody for obesity.
$1.91
Pre-market+0.06 (+3.24%)
At close$1.85(+2.78%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions45 holders · as of Jun 30, 2026 | 45.24% | 2.00M shares | |
| Insiders6 holders · as of Aug 20, 2026 | 31.92% | 1.41M shares | |
| Otherremainder | 22.84% | 1.01M shares |
4.43M company shares as of Sep 3, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Institutions13F, as of Jun 30, 2026
45 holders · 16.03M shares · 8 new positions · 10 increased · 12 reduced · 3 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| 5Am Venture Management, LLC | 9.68M | 218.66% | 0 | Aug 14, 2026 |
| Versant Venture Management, LLC | 2.01M | 45.34% | 0 | Aug 12, 2026 |
| Baker Bros. Advisors LP | 1.58M | 35.58% | 0 | Aug 14, 2026 |
| Vanguard Capital Management LLC | 763.9K | 17.25% | −575 | Aug 13, 2026 |
| Sphera Funds Management Ltd. | 678.9K | 15.33% | 0 | Aug 14, 2026 |
| Platinum Investment Management Ltd | 233.1K | 5.26% | 0 | Aug 13, 2026 |
| BlackRock, Inc. | 232.9K | 5.26% | −53.3K | Aug 7, 2026 |
| Geode Capital Management, LLC | 218.1K | 4.92% | −59.2K | Aug 12, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Andrew J. Schwabincl. Scott M. Rocklage, 5AM Partners II, LLC +6 more | 30.20% | 13D | Aug 18, 2026 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 20, 2026 | 5AM Partners VII, LLC10 percent owner | Sale · 3 lots | 7,700 | $0.3200 | 55,208 |
| Aug 19, 2026 | 5AM Partners VII, LLC10 percent owner | Sale · 3 lots | 68,140 | $0.3500 | 55,254 |
| Aug 18, 2026 | 5AM Partners VII, LLC10 percent owner | Sale · 3 lots | 300,000 | $0.3800 | 55,663 |
| Aug 20, 2026 | Andrew J. Schwabdirector, 10 percent owner: | Sale · 3 lots | 7,700 | $0.3200 | 55,208 |
| Aug 19, 2026 | Andrew J. Schwabdirector, 10 percent owner: | Sale · 3 lots | 68,140 | $0.3500 | 55,254 |
| Aug 18, 2026 | Andrew J. Schwabdirector, 10 percent owner: | Sale · 3 lots | 300,000 | $0.3800 | 55,663 |
CongressHouse and Senate disclosures
Not reported.
